Phase 0 Study of Vandetanib-Eluting Radiopaque Embolics as a Preoperative Embolization Treatment in Patients with Resectable Liver Malignancies.
Beaton L, Tregidgo HFJ, Znati SA, Forsyth S, Counsell N, Clarkson MJ, Bandula S, Chouhan M, Lowe HL, Thin MZ, Hague J, Sharma D, Pollok JM, Davidson BR, Raja J, Munneke G, Stuckey DJ, Bascal ZA, Wilde PE, Cooper S, Ryan S, Czuczman P, Boucher E, Hartley JA, Atkinson D, Lewis AL, Jansen M, Meyer T, Sharma RA.
Beaton L, et al. Among authors: munneke g.
J Vasc Interv Radiol. 2022 Sep;33(9):1034-1044.e29. doi: 10.1016/j.jvir.2022.04.033. Epub 2022 May 5.
J Vasc Interv Radiol. 2022.
PMID: 35526675